March 25, 2026 - ET (Eastern Time, GMT-05:00)
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
Building influence without authority
Emotional intelligence in high-stakes financial environments
Personal brand development
Learning through change and uncertainty
Cross-cultural communication in global life sciences operations
Networking for career advancement
CPE Credits Available 1.0
- Laura Klein - Director, Consolidations and Financial Reporting, Bristol Myers Squibb
- Mallory Morales - Senior Vice President Finance, Chief Accounting Officer, Treasurer, Immuneering Corporation
- Tara Ruggeri - Head of Global Transaction Support, Sanofi
- Thomas Cunningham - Associate Vice President, Corporate Accounting and External Reporting, Merck
Most Favored Nation pricing models: financial implications and response strategies
Tariffs and trade barriers: quantifying the P&L impact from clinical supply, inventory, and COGS
Big Beautiful Bill impact
CPE Credits Available 1.0
California Climate Disclosure Laws
CSRD
Staying up to date on the changing regulatory landscape
Preparation for assurance
CPE Credits Available 1.0
- Marc Siegel - Former Board Member, FASB and SASB
- Sarah Stiff - ESG Controller, Legend Biotech
- Nathan Knies - Director, Sustainability Controller, Eli Lilly & Co.
- Matthew Rickert - Director, Sustainability Controller, Solventum Corporation
The Roundtables session provides an engaging and interactive forum to engage in focused small-group discussions to exchange ideas, share insights, and discuss key challenges shaping the industry. This dynamic format fosters open dialogue and collaborative problem-solving, creating a space for industry professionals to connect, learn, and explore innovative approaches in a focused and time-efficient setting.
Example themes include:
Financial Planning & Analysis Transformation
Revenue Recognition
Clinical Trial Financial Management
Professional Development, Upskilling and Career Paths
Enterprise Risk Management
AI Strategy and Compliance
CPE Credits Available 1.0
- Tyler Mead - Senior Manager, Financial Reporting and Internal Controls, Immuneering Corporation
- Gina Tracey - Vice President, Corporate Controller, Alnylam Pharmaceuticals
- Robert Auslander - Vice President, Head of Internal Audit & Risk, Bausch & Lomb, Adjunct Professor Yeshiva University - Auditing
- Hikmete O'Brien - Controller, Laxxon Medical
- Meagan Caldwell - Senior Director of Technical Accounting, Sumitomo Pharma America, Inc
Technical deep dives
Industry-specific applications
Emerging trends and future focus
CPE Credits Available 1.0
- Katy Rossino - Partner, Deloitte & Touche LLP
- Grant Kluesner - Senior Manager, Deloitte & Touche LLP
- Michael Kirk - Senior Manager, Deloitte & Touche LLP
- Eric Benson - Senior Manager, Deloitte & Touche LLP
Evolving Audit Committee Priorities in Life Sciences
Financial Reporting Quality and Transparency
Risk Oversight Beyond Traditional Financial Concerns
Audit Committee and External Auditor Dynamics
Internal Audit Function Effectiveness
Board and Committee Effectiveness
CPE Credits Available 1.0
- Rene Salas - Board Member/Financial Expert, ADMA Biologics, Inc.
Following an immersive 2.5 days of knowledge infusion, you now have a unique opportunity to delve deeper into your acquired insights. Engage in interactive working group discussions, where you will have the opportunity to dissect your recent learnings and foster peer interactions that not only cultivate new relationships but also reinvigorate your professional objectives as you return to your workplace.
CPE Credits Available 1.0
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson